InVivoMAb anti-human PD-1 (CD279)

BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody. Sanlorenzo M et al., 2018 Jul 15, Clin Cancer Res

Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines. Yamane H et al., 2015, Am J Cancer Res

Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. Bennett F et al., 2003 Jan 15, J Immunol